| Patient | Hatshepsut |
|---|---|
| Date of birth | 1978-02-10 |
| Identifiers | MRN HR-AC006-SYN; SSN (made up) 000-06-9440 |
| Document date | 2026-05-26 |
| Author | Amunet Okafor-Harrington, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week review: healing after the extraction, diabetes, eye and foot screening, and cardiovascular risk. [S]
Ms. Hatshepsut returns six weeks after the extraction. The socket healed without trouble and she finished the two weeks of chlorhexidine; she is chewing on both sides again. She takes metformin 1000 mg with the evening meal without stomach upset. Her thirst and night urination have eased. She has been to two of the diabetes education and nutrition sessions and has cut down on sweet tea and dates. She would like to lose some weight to make the stairs easier, and asks about the weekly injections she has read about. Her knees hurt less since she began the strengthening exercises and the gel. [S]
| Element | Detail |
|---|---|
| Mouth | Socket healed; chewing on both sides |
| Diabetes | Metformin 1000 mg tolerated; two education sessions; thirst eased |
| Her goal | Climb stairs at the sites more easily; interested in a GLP-1 medicine |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; energy better |
| Ears, nose, mouth, and throat | Negative | No dental pain or swelling |
| Gastrointestinal | Negative | No nausea, diarrhea or abdominal pain |
| Musculoskeletal | Positive | Knee pain on stairs, better with exercises |
| Neurological | Negative | No numbness or tingling in the feet |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 400 mg oral tablet, one tablet by mouth every six hours as needed for dental pain, with food, for up to one week | One tablet every six hours as needed, with food; no more than four a day | Oral route | 2026-04-14 to 2026-04-22 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets (1 g) by mouth every six hours as needed for dental pain, alternating with ibuprofen, no more than 3 g a day, for up to one week | Two tablets every six hours as needed; no more than six a day | Oral route | 2026-04-14 to 2026-04-22 | completed | S |
| Metformin extended-release 500 mg tablet, one tablet with the evening meal for one week, then two tablets (1000 mg) with the evening meal | One tablet with the evening meal for a week, then two | Oral route | 2026-04-14 | active | S |
| Diclofenac sodium 1% gel, 4 g to each painful knee up to four times a day as needed | 4 g to each knee up to four times a day as needed | Topical route | 2026-04-14 | active | S |
| Chlorhexidine gluconate 0.12% oral rinse, 15 mL swished for 30 seconds and spat out twice daily for two weeks after the extraction | 15 mL rinse twice daily for two weeks | Oral route | 2026-04-15 to 2026-04-29 | completed | S |
| Semaglutide 0.25 mg subcutaneous injection once weekly (starting dose, planned for four weeks) | 0.25 mg once weekly | Subcutaneous route | 2026-05-26 to 2026-06-30 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet daily | Oral route | 2026-05-26 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-26 | Body height | 160 | cm | S |
| 2026-05-26 | Body weight | 91.5 | kg | S |
| 2026-05-26 | Body mass index (BMI) [Ratio] | 35.7 | kg/m2 | S |
| 2026-05-26 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-05-26 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-26 | Heart rate | 78 | /min | S |
| 2026-05-26 | Respiratory rate | 14 | /min | S |
| 2026-05-26 | Body temperature | 36.7 | Cel | S |
| 2026-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Vital signs recorded on 2026-05-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 91.5 kg, BMI 35.7; blood pressure 124/78, pulse 78 |
| Mouth | Socket of tooth 19 healed; gums red with calculus |
| Feet | Normal 10-g monofilament and vibration sense; dorsalis pedis and posterior tibial pulses present; no callus, ulcer or deformity |
| Knees | Crepitus in both knees; no effusion; full range |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Painful swelling of the left lower jaw for four days, after a throbbing toothache for three weeks under a broken lower left molar; low-grade temperature, no trismus, no swelling of the floor of the mouth or neck; dental abscess suspected | resolved | confirmed | R68.84 | S — Synthetic presenting concern at the index visit, superseded by the dental diagnosis the next day. It echoes the dental disease reported on the mummy identified as hers (R, after the index date), without linking to it. |
| Acute periapical abscess of the lower left first molar (tooth 19), non-restorable, with a localized buccal vestibular swelling and no spread to fascial spaces; drained and extracted | resolved | confirmed | K04.7 | S — Synthetic modern diagnosis; no historical claim is made. |
| Type 2 diabetes found on screening (hemoglobin A1c 7.6% with a random glucose of 212 mg/dL from the same sample), with thirst and waking at night to pass urine; normal kidney function and urine albumin | active | confirmed | E11.65 | S — Synthetic screening finding at intake; not linked to the disputed claim of diabetes on the mummy (R). |
| Obesity, class 2 (BMI 36.3), with type 2 diabetes and knee osteoarthritis; she wants to feel stronger and move more easily | active | confirmed | E66.812 | S — Synthetic finding at intake, recorded in person-first language. |
| Primary osteoarthritis of both knees: pain on stairs and after standing, morning stiffness under 30 minutes, crepitus, no effusion; a clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic finding at intake; not linked to the osteoarthritis reported on the mummy (R). |
| Periodontitis, generalized, stage III, grade C (bone loss to the middle third of the roots, two molars lost earlier to gum disease, and A1c above 7% as a grade modifier) | active | confirmed | K05.323 | S — Synthetic finding at the dental consultation. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Hemoglobin A1c | Every three months until at goal or after a change in therapy, then every six months | Due | 7.6% at diagnosis six weeks ago; next at about three months |
| Examination | Blood pressure (goal below 130/80) | Every visit | Completed today | 124/78 |
| Examination | Weight and BMI, recorded with her permission | Every visit | Completed today | 91.5 kg, BMI 35.7 |
| Medication safety | Metformin: dose, tolerance and sick-day rules | Every visit | Completed today | 1000 mg tolerated; sick-day rules reviewed |
| Medication safety | GLP-1 receptor agonist: dose, nausea, warning signs | At start and every visit | Completed today | Semaglutide 0.25 mg weekly started; nausea, pancreatitis, gallbladder and pregnancy advice given |
| Medication safety | Hypoglycemia review | Every visit | Not indicated | Metformin and semaglutide do not cause hypoglycemia on their own |
| Examination | Comprehensive foot examination | At diagnosis, then yearly | Completed today | Normal |
| Imaging | Diabetic eye screening | At diagnosis, then every one to two years | Completed today | Retinal photographs: no retinopathy |
| Laboratory | Urine albumin-to-creatinine ratio and eGFR | At diagnosis, then yearly | Up to date | UACR 18 mg/g and eGFR 103 at intake |
| Laboratory | Lipid panel and ALT on a statin | Baseline, then 4 to 12 weeks after starting a statin | Due | Atorvastatin started today; ALT 31 U/L at baseline; lipids and ALT at the next review |
| Self-management | Diabetes self-management education and nutrition therapy | At diagnosis, then yearly | Completed today | Two of four sessions attended |
| Examination | Dental and periodontal care | At diagnosis, then periodontal maintenance every three months | Completed today | Socket healed; scaling and root planing booked |
| Examination | Knee pain and function | Every visit | Completed today | Better with exercise and gel |
Goal progress:
Guideline basis: Standards of Care in Diabetes—2026 (Section 2, Diagnosis and Classification of Diabetes; Section 9, Pharmacologic Approaches to Glycemic Treatment) (2026); Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes—2026 (Section 8) (2026); Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (Section 10) (2026); Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology (2018); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); CMID: Clinical Monitoring Intelligence Database, diabetes type 2, rheumatoid arthritis and osteoarthritis, and hyperlipidemia monographs (2026)
Follow-up: Preventive visit as booked; fourteen-week review with A1c, lipids and ALT. Next scheduled visit 2026-06-30: periodic adult preventive visit. [S]